CERo Therapeutics Holdings, Inc. (CERO) NASDAQ

0.46

+0.0181(+4.06%)

Updated at June 02 02:55PM

Currency In USD

Valuation

Market Cap14.5M
Enterprise Value12.74M
P/E Ratio-0.11
PEG Ratio0
Price/Sales Ratio3.08
Price/Book Ratio-4.82
Enterprise/Revenue-0.22
Enterprise/EBITDA0.02

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-11.95
Operating Margin-14.27

Management Effectiveness

Return On Assets-1.74
Return On Equity6.61

Income Statement

Revenue0
Revenue/Share0.34
Gross Profit0
EBITDA-7.14M
Net Income-11.09M
Diluted EPS-4.59

Balance Sheet

Total Cash5.2M
Total Cash/Share1.52
Total Debt1.37M
Total Debt/Equity-4.15
Current Ratio0.73
Book Value Per Share-0.1

Price History

52-Week Change-99.5
52-Week High102
52-Week Low0.4
Moving Average 50 Days0.72
Moving Average 200 Days6.44

Statistics

Average Volume1.92M
Shares Outstanding7.72M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:100
Last Split DateJanuary 08, 2025